Revised SPC: Sirturo (bedaquiline fumarate) 100mg tablets
Bedelaquine is now licensed as part of an appropriate combination regimen for pulmonary multidrug‑resistant tuberculosis, in adolescents aged over 12 years. The entire SPC has been updated with information for use in this population
Source:
electronic Medicines compendium